Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2009-10-28
2011-12-06
Anderson, James D (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C514S506000, C514S578000
Reexamination Certificate
active
08071646
ABSTRACT:
The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.
REFERENCES:
patent: 5502077 (1996-03-01), Breivik et al.
patent: 5656667 (1997-08-01), Breivik et al.
patent: 5698594 (1997-12-01), Breivik et al.
patent: 6365176 (2002-04-01), Bell et al.
patent: 6624195 (2003-09-01), Horrobin
patent: 2003/0012827 (2003-01-01), Stoll
patent: 2005/0245610 (2005-11-01), Verboom et al.
patent: 2006/0211762 (2006-09-01), Rongen et al.
patent: 1157692 (2001-11-01), None
patent: 0023069 (2000-04-01), None
patent: 2005070411 (2005-08-01), None
patent: 2006017692 (2006-02-01), None
patent: 2006085144 (2006-08-01), None
Dorland's Medical Dictionary for Healthcare Consumers, “dyslipidemia”, 2007, pp. 1 of 1.
Perry, “Omega-3 for bipolar disorder—Restoring the balance”, Sep. 2001, Food and Behaviour Research, pp. 1-9 of 9, downloaded from “http://www.fabresearch.org/uploads/1503/2001%20Andrew%20Stoll%20Interview%20-%20Omega-3%20and%20Bipolar.pdf”.
Stoll, The Omega-3 Connection, Simon & Schuster. 2001, pp. 212-215 provided.
OmegaBrite® omega-3 supplement (pp. 1-4 of 4, downloaded from “http://omegabrite.com” on Sep. 10, 2008, publicly known on or prior to 2001 as evidenced by disclosure of the product by Stoll, supra.
Rumsfeld, J.S. and P.M. Ho. “Depression and Cardiovascular Disease: A Call for Recognition,” Circulation (2005) 111: 250-253.
Viachopoulos, C. et al. “Acute System Inflammation Increases Artertial Stiffness and Decreases Wave Reflections in Healthy Individuals,” Circulation (2005) 112: 2193-2220.
Pharmaceutical Grade Fish Oil, Product Reviews [Online] Oct. 14, 2003, XP002431628 Retrieved from the Internet: URL:http://www.fishoilreview.com/[retrieved on Apr. 26, 2007].
Nakamura K et al: “Influence of preoperative administration of omega-3 fatty acid-enriched supplement on inflammatory and immune responses in patients undergoing major surgery for cancer” Nutrition, Nutrition, Burbank CA, US, vol. 21, No. 6, Jun. 2005, pp. 639-649, XP004940931 ISSN: 0899-9007.
Moyard: “An Introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: Part II” Urologic Oncology, Elsevier, New York, NY US, vol. 23, No. 1, Jan. 2005, pp. 36-48, XP004883101 ISSN: 1708-1439.
Sontrop et al: “omega-3 polyunsaturated fatty acids and depression: A review of the evidence and a methodological critique” Preventive Medicine, Academic Press, XX, vol. 42, No. 1, Dec. 7, 2005, pp. 4-13, XP005291367 ISSN: 0091-7435/.
Defilippis et al: “Understanding omega-3's” American Heart Journal, Mosby-Year Book Inc., St. Louis, MO, US, vol. 151, No. 3, Mar. 2006, pp. 564-570, XP005587549 ISSN: 0002-8703.
International Search Report for International Application No. PCT/US2006/048696. Mailed May 23, 2007.
Written Opinion of the International Search Authority for International Application No. PCT/US2006/048696. Mailed May 23, 2007.
Barnett et al., Annals of Thoracic Surgery, 2003, vol. 76, pp. 726-731.
“Causes of Depression”, Depression.com, 1 page, downloaded from “http://www.depression.com/causes—of—depression.html” on Sep. 11, 2008.
Coric Ann
Feuerstein Seth D.
Sanfilippo Louis C.
Anderson James D
Cenestra LLC
Hogan & Lovells US LLP
Polansky Gregg
LandOfFree
Omega 3 fatty acid formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Omega 3 fatty acid formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Omega 3 fatty acid formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4265960